GDC-0068 in Subjects with locally advanced / metastatic adenocarcinoma

• Research type

  Research Study

• Full title

  A RANDOMIZED, PHASE II,PLACEBO-CONTROLLED STUDY OF GDC-0068, AN INHIBITOR TO AKT, IN COMBINATION WITH FLUOROPYRIMIDINE PLUS OXALIPLATIN IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

• IRAS ID

  115683

• Contact name

  Ian Chau

• Contact email

  ian.chau@rmh.nhs.uk

• Sponsor organisation

  Genentech Inc.

• Eudract number

  2012-002080-10

• ISRCTN Number

  N/A

• REC name

  East of England - Essex Research Ethics Committee

• REC reference

  13/EE/0216

• Date of REC Opinion

  29 Oct 2013

• REC opinion

  Further Information Favourable Opinion